EASY BIO,Inc. Statistics

Total Valuation

EASY BIO,Inc. has a market cap or net worth of KRW 130.23 billion. The enterprise value is 288.86 billion.

Market Cap	130.23B
Enterprise Value	288.86B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

EASY BIO,Inc. has 34.14 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Shares Outstanding	34.14M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	1.30%
Owned by Institutions (%)	0.86%
Float	17.10M

Valuation Ratios

The trailing PE ratio is 7.52.

PE Ratio	7.52
Forward PE	n/a
PS Ratio	0.53
PB Ratio	1.86
P/FCF Ratio	4.69
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.71, with an EV/FCF ratio of 10.40.

EV / Earnings	16.66
EV / Sales	1.18
EV / EBITDA	9.71
EV / EBIT	11.34
EV / FCF	10.40

Financial Position

The company has a current ratio of 1.82, with a Debt / Equity ratio of 2.95.

Current Ratio	1.82
Quick Ratio	0.93
Debt / Equity	2.95
Debt / EBITDA	7.24
Debt / FCF	7.76
Interest Coverage	4.69

Financial Efficiency

Return on equity (ROE) is 27.23% and return on invested capital (ROIC) is 7.51%.

Return on Equity (ROE)	27.23%
Return on Assets (ROA)	6.47%
Return on Capital (ROIC)	7.51%
Revenue Per Employee	1.93B
Profits Per Employee	136.51M
Employee Count	127
Asset Turnover	1.00
Inventory Turnover	4.60

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +19.97% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+19.97%
50-Day Moving Average	3,976.80
200-Day Moving Average	3,924.88
Relative Strength Index (RSI)	47.10
Average Volume (20 Days)	99,452

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EASY BIO,Inc. had revenue of KRW 245.53 billion and earned 17.34 billion in profits. Earnings per share was 507.55.

Revenue	245.53B
Gross Profit	73.06B
Operating Income	25.46B
Pretax Income	23.25B
Net Income	17.34B
EBITDA	29.76B
EBIT	25.46B
Earnings Per Share (EPS)	507.55

Full Income Statement

Balance Sheet

The company has 60.17 billion in cash and 215.58 billion in debt, giving a net cash position of -155.41 billion or -4,552.55 per share.

Cash & Cash Equivalents	60.17B
Total Debt	215.58B
Net Cash	-155.41B
Net Cash Per Share	-4,552.55
Equity (Book Value)	73.13B
Book Value Per Share	2,047.97
Working Capital	93.26B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 32.26 billion and capital expenditures -4.48 billion, giving a free cash flow of 27.78 billion.

Operating Cash Flow	32.26B
Capital Expenditures	-4.48B
Free Cash Flow	27.78B
FCF Per Share	813.73

Full Cash Flow Statement

Margins

Gross margin is 29.75%, with operating and profit margins of 10.37% and 7.06%.

Gross Margin	29.75%
Operating Margin	10.37%
Pretax Margin	9.47%
Profit Margin	7.06%
EBITDA Margin	12.12%
EBIT Margin	10.37%
FCF Margin	11.31%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.62%.

Dividend Per Share	100.00
Dividend Yield	2.62%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	1
Payout Ratio	20.07%
Buyback Yield	0.01%
Shareholder Yield	2.64%
Earnings Yield	13.30%
FCF Yield	21.33%

Dividend Details

Stock Splits

The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.

Last Split Date	Dec 21, 2020
Split Type	Forward
Split Ratio	5

Scores

EASY BIO,Inc. has an Altman Z-Score of 1.78. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.78
Piotroski F-Score	n/a